Evidence map›Paper›PMID 24802384›Full record

ArticleGlobal health action2014

Measuring causes of adult mortality in rural northern Malawi over a decade of change.

Judith R Glynn, Clara Calvert, Alison Price, Menard Chihana, Lackson Kachiwanda, Sebastian Mboma, Basia Zaba, Amelia C Crampin

Abstract read
In one paragraph

Article in Global health action, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Observational
  8. High mortality and prevalence of HIV and tuberculosis in adults with chronic cough in Malawi: a cohort study.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2016
    Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Judith R GlynnLondon School of Hygiene and Tropical Medicine, University of London, London, UK; judith.glynn@lshtm.ac.uk.
Clara CalvertLondon School of Hygiene and Tropical Medicine, University of London, London, UK.
Alison PriceLondon School of Hygiene and Tropical Medicine, University of London, London, UK; Karonga Prevention Study, Chilumba, Malawi.
Menard ChihanaKaronga Prevention Study, Chilumba, Malawi.
Lackson KachiwandaKaronga Prevention Study, Chilumba, Malawi.
Sebastian MbomaKaronga Prevention Study, Chilumba, Malawi.
Basia ZabaLondon School of Hygiene and Tropical Medicine, University of London, London, UK.
Amelia C CrampinLondon School of Hygiene and Tropical Medicine, University of London, London, UK; Karonga Prevention Study, Chilumba, Malawi.

Funding

Wellcome Trust 098610Wellcome Trust 101594
6 · The paper itself

Abstract

backgroundVerbal autopsy could be more widely used if interpretation by computer algorithm could be relied on. We assessed how InterVA-4 results compared with clinician review in diagnosing HIV/AIDS-related deaths over the period of antiretroviral (ART) roll-out.

designIn the Karonga Prevention Study demographic surveillance site in northern Malawi, all deaths are followed by verbal autopsy using a semi-structured questionnaire. Cause of death is assigned by two clinicians with a third as a tie-breaker. The clinician review diagnosis was compared with the InterVA diagnosis using the same questionnaire data, including all adult deaths from late 2002 to 2012. For both methods data on HIV status were used. ART was first available in the district from 2005, and within the demographic surveillance area from 2006.

resultsThere were 1,637 adult deaths, with verbal autopsy data for 1,615. Adult mortality and the proportion of deaths attributable to HIV/AIDS fell dramatically following ART introduction, but for each year the proportion attributed to HIV/AIDS by InterVA was lower than that attributed by clinician review. This was partly explained by the handling of TB cases. Using clinician review as the best available 'gold standard', for those aged 15-59, the sensitivity of InterVA for HIV/AIDS deaths was 59% and specificity 88%. Grouping HIV/AIDS/TB sensitivity was 78% and specificity 83%. Sensitivity was lower after widespread ART use.

conclusionsInterVA underestimates the proportion of deaths due to HIV/AIDS. Accepting that it is unrealistic to try and differentiate TB and AIDS deaths would improve the estimates. Caution is needed in interpreting trends in causes of death as ART use may affect the performance of the algorithm.

Indexed as

AdolescentAdultAge FactorsAnti-HIV AgentsCause of DeathFemaleHIV InfectionsHumansMalawiMaleMiddle AgedMortalityPopulation SurveillanceRisk FactorsRural PopulationYoung AdultAnti-HIV AgentsAfricaantiretroviral therapyHIVmortalityverbal autopsy

Identifiers

PMID24802384
PMCPMC4007026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.